Knowledge of Living Will in Patients With Rheumatic Diseases

Recruiting

• Conditions: Rheumatic Disorder

• Registration Number: NCT05676359
• Lead Sponsor: National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Brief Summary

The living will is a legal document derived from a communication and deliberation process, medical ethical aspect, currently regulated in Mexico by the General Health Law and the Health Law of Mexico City.

Knowledge of living will in the population with chronic diseases, including rheumatic diseases, has been little addressed. Most patients do not know what the living will document is, so they do not carry it out and others, despite knowing it, have a passive attitude toward doing it.

Detailed Description

A study will be carried out on patients with rheumatic diseases and healthy family controls. Patients will be selected from those attending the Department of Immunology and Rheumatology in Mexico City outpatient department, including consecutive cases.

The patients will be assessed for their quality of life and disability. Patients and controls will be evaluated on the knowledge of living will, their perceptions about specific health outcomes, sociodemographic characteristics, comorbidities, and psychiatric pathology.

Study Timeline

• Study First Submitted: 2022-12-15
• Study First Submitted QC: 2023-01-06
• Study First Posted: 2023-01-09
• Study Start: 2023-02-01
• Primary Completion: 2023-07-31
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-23
• Last Update Posted: 2023-09-26
• Study Completion: 2024-07-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 157

Inclusion Criteria

Cases

• Patients with a rheumatic disease diagnostic by a rheumatologist
• Patients with rheumatic diseases attending the Department of Immunology and Rheumatology in Mexico City outpatient department
• Patients who agree to participate in the study, who complete and sign the informed consent Controls
• Relative of a patient with rheumatic diseases of the same sex and age ± 5 years, without known rheumatic and/or chronic disease and without the use of pharmacological treatment for more than 7 days during the month before study entry.

Exclusion Criteria

Cases

• Patients with severe diseases or in palliative care by a rheumatologist

Controls

• Withdrawal of the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Knowledge of the living will with the living will questionnaire (locally development)	1 day At study inclusion (After their rheumatology consultation)	To evaluate the knowledge of the living will, using the living will questionnaire (locally development), among the patients with rheumatic diseases and healthy controls.
Perceptions of Health Outcomes with the perceptions of health outcomes questionnaire (locally development)	1 day At study inclusion (After their rheumatology consultation)	To evaluate the perceptions of the of health outcomes using the perceptions of health outcomes questionnaire (locally development), among the patients with rheumatic diseases and healthy controls

Trial Locations

Locations (1)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán; 🇲🇽 Mexico City, Mexico